Global Live Cell Imaging Industry ReportForecast to 2023 is latest research report published by “Market Research Future”, which provides comprehensive information on Live Cell Imaging Market – Trends, Size, Share, Statistics with historic and forecast data to 2023.
The live cell imaging market is eyeing for an impressive growth at a stupendous 9% CAGR during the forecast period (2018-2023). Live cell imaging simply put, is the utilization of time lapse microscopy for studying the living cells. It is used by scientists to have a better understanding about the biological functions through cellular dynamics.
This technique has turned immensely popular especially in the healthcare domain. Live cell imaging is used in various application. It is used to understand the dynamic processes and cellular structures, to study endocytosis and exocytosis, cellular integrity, enzyme activity, protein trafficking and localization of molecules.
Besides, it is broadly applied for monitoring the molecules especially in live animals. Pharmaceutical companies are utilizing live cell imaging methods to create new medicines.
There are numerous factors that is driving the growth of the live cell imaging market. These factors according to MRFR (Market Research Future) report include increasing use of high-content screening methods in drug discovery, increasing cases of cancer, higher funding from the government for research and development activities, use in high content screening in cell biology and drug discovery and rising incidences of chronic diseases.
On the contrary, factors such as dearth of skilled professionals coupled with soaring price of high-content screening systems may hamper the growth of the live cell imaging market.
Leading players profiled in the live cell imaging market include Thermo Fisher Scientific, Inc. (U.S.)., BioTek Instruments (U.S.), Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), PerkinElmer, Inc. (U.S.), GE Healthcare (U.K.), Molecular Devices, LCC (U.S.), Sigma-Aldrich Corporation (U.S.), Nikon Corporation (Japan), Olympus Corporation (Japan), Carl Zeiss AG (Germany), and Leica Microsystems (Germany).
MRFR report offers a complete segmental analysis of the live cell imaging market on the basis of products, technology, application and end-user.
Based on products, it is segmented into software, consumables and equipment. Of these, equipment will have the largest share in the market during the forecast period followed by consumables.
Based on technology, the live cell imaging market is segmented into Multiphoton Excitation Microscopy, Total Internal Reflection Fluorescence Microscopy, Fluorescence in Situ Hybridization, Ratiometric Imaging, High-Content Analysis, Fluorescence Recovery After Photobleaching and Fluorescence Resonance Energy Transfer. Of these, Fluorescence Resonance Energy Transfer will dominate the market during the forecast period.
Based on application, it is segmented into drug discovery, developmental biology, stem cells, cell biology and others. Of these, cell biology will have the largest share in the market.
Based on end-user, the live cell imaging market is segmented into diagnostic laboratories, hospitals, biotechnology companies, pharmaceutical companies and others.
By region, the live cell imaging market covers growth opportunities and latest trends across Europe, North America, Asia Pacific and Rest of the World. Of these, North America will govern the market owing to substantial investments made in the research and development activities especially in pharmaceutical and biotech sectors, presence of a well-established healthcare system, rising incidence of cancer, advancements in technology, increasing capitalization in the imaging systems, presence of key players in the region and strong economic conditions.
Europe holds the second major share in the live cell imaging market owing to increased focus in R&D in the biotechnology domain, government funds for research and development expenditure, increasing incidences of chronic diseases and presence of notable players. The live cell imaging market in the APAC region will emerge rapidly as a highly promising market during the forecast period on account of growing research laboratories, quickly improving economic conditions, developing healthcare technology and increasing cancer research activities.
Japan will account for the largest share here owing to growing need for live cell imaging techniques and growing incidences of cancer. In China, on the other hand, factors such as accessibility of affordable diagnostic and treatment choices and rising geriatric population will spur the market growth.
The live cell imaging market is competitive and fragmented with the key players dominating the market. They are undertaking various strategies namely expansions, partnerships and product launches for strengthening their position.
Dec 2018- Swedish bioprinting materials and 3D bioprinters manufacturer, CELLINK has partnered with San Francisco based biotechnology company, Prellis Biologics for commercializing high-resolution micro bioprinting and holographic technology.
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
To view the original version on ABNewswire visit: Live Cell Imaging Market Share, Size, Trends, Growth, Global Demand, Regional Overview and Forecast by 2023 | Finds MRFR
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact email@example.com